Drug intelligence / Profile preview

hepatitis A vaccine

Development stage
Approved
Lead developer
GSK
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Hepatitis A vaccine is a biologic preparation used to provide active immunity against the hepatitis A virus (HAV). Most globally available formulations consist of whole-cell inactivated virus (such as the HM175 strain), although live attenuated versions are utilized in specific regions like China. The vaccine is typically administered as a two-dose series via intramuscular injection and is highly effective at preventing infection and subsequent liver disease. It is recommended for routine pediatric immunization, travelers to endemic areas, and individuals with chronic liver disease or other high-risk factors. Major developers and manufacturers include GSK, Merck, and Sanofi.

Brand names
HavrixVaqtaAvaximEpaxalHealive
Other names
Hepatitis A virus vaccineHepA vaccineinactivated hepatitis A vaccine

Beyond the preview

Go deeper on hepatitis A vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hepatitis A vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call